How Does Cobenfy Work, and How Is It Different From Other Medicines Used to Treat Schizophrenia? An imbalance of brain chemicals called neurotransmitters may contribute to schizophrenia. Current ...

Lizzie Duszynski-Goodman is a journalist living in the Midwest with her husband and two young children. Her work explores the intersection of mental health, wellness and parenting. She is the former ...

Schizophrenia is a complicated mental illness that can be hard to treat. Antipsychotic drugs greatly improve symptoms for many people. But about a third of those with the condition have what’s called ...

Credit: Getty Images A literature review of nonpharmacologic treatments for patients with schizophrenia and comparison recommendations in the 2020 American Psychiatric Association Practice (APA) ...

The Food and Drug Administration on Thursday approved Bristol Myers Squibb's highly anticipated schizophrenia drug Cobenfy, the first novel type of treatment for the debilitating, chronic mental ...

The US Food and Drug Administration (FDA) is poised to regulate a "potential first-in-class antipsychotic", known as KarXT, said Medscape. About one in 300 people worldwide are affected by ...

Electroconvulsive therapy (ECT) is a treatment for severe mental health conditions, including schizophrenia. Though it’s more commonly used to treat major depressive disorder and bipolar disorder, ECT ...

Adults with resistant schizophrenia have significant gut microbiome differences compared with their counterparts who respond to treatment, a new finding that researchers speculate may be driven by ...

Schizophrenia is a serious mental disorder involving changes in perception, thoughts, and behaviors. It typically involves a disconnection from reality, in which a person experiences hallucinations ...

Schizoaffective disorder is characterized by psychotic symptoms similar to schizophrenia, such as hallucinations and delusions, along with the presence of a mood disorder like mania or depression.

The general consensus among experts is that TRS is a condition in which an individual’s symptoms haven’t responded to two or more antipsychotic medicines given at a therapeutic dose for at least six ...